McIndoe named director of MCG Center for Biotechnology and Genomic Medicine – Jagwire

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Dr. Richard McIndoe, a bioinformatics expert who served as assistant director of the Center for Biotechnology and Genomic Medicine at Augusta University’s Medical College of Georgia for nearly two decades, is the new director of the center.

McIndoe, who is also Regents’ Professor in the MCG Department of Obstetrics and Gynecology, took up his new role on October 1st.

He is a lead researcher on several million dollar government grants, including a new $ 6.2 million initiative to support highly innovative research ideas in three areas with huge health implications. The Innovative Science Accelerator (or ISAC) program establishes an expedited yet comprehensive review process that allows scientists to pursue some of their most innovative research ideas in diseases of the kidney, urinary tract in both sexes, male reproductive organs, and blood and bone marrow.

The aim is to advance the science that is important to people’s lives and the opportunities are to give new scholars in particular experience in writing scholarships, going through the peer review process and generating results.

For the past 20 years, McIndoe has also led the coordination and bioinformatics units for three national consortia funded by the National Institute of Diabetes and Digestive and Kidney Diseases. The Animal Models of Diabetic Complications Consortium had primary responsibility for the development and characterization of animal models that mimick human diabetic complications, with the task of creating these models and providing them along with the data relevant to their characterization and the protocols for their generation Analysis, to the scientific community. The consortium consisted of 13 Pathobiology Sites, a Mouse Generation and Husbandry Core, and the CBU with researchers from 15 different institutions in the United States.

The mouse metabolic phenotyping centers are tasked with providing the scientific community with standardized, high-quality services for metabolic and physiological phenotyping of mice. The five centers nationwide make state-of-the-art technologies available to investigators for a fee.

The Diabetic Complications Consortium provides a cross-section of support to advance science and patient care, including funding short-term animal or human studies to better understand and prevent complications, the leading cause of diabetes-related death.

He is also the lead investigator of the nearly 20-year-old federally funded study The Environmental Determinants of Diabetes in the Young (or TEDDY), which aims to find out how genetics and environmental triggers collide to cause type 1 diabetes.

McIndoe received his PhD in Immunology and Molecular Pathology from the University of Florida in 1991. He joined the MCG faculty in 2002 and was awarded the Georgia Research Alliance Distinguished Investigator Award in 2008 as an aspiring research and development director at a research university in Georgia.

To like

To like